| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.812 | 0 |
| Total Expenses - EUR | 544 | 0 | 0 | 0 | 0 | 0 | 51 | 24 | 729 | 57 |
| Gross Profit/Loss - EUR | -544 | 0 | 0 | 0 | 0 | 0 | -51 | -24 | 15.083 | -57 |
| Net Profit/Loss - EUR | -544 | 0 | 0 | 0 | 0 | 0 | -51 | -24 | 15.083 | -57 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Adibiocris S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 754 | 747 | 734 | 721 | 707 | 693 | 678 | 680 | 3 | 3 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 754 | 747 | 734 | 721 | 707 | 693 | 678 | 680 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 |
| Shareholders Funds | -16.732 | -16.561 | -16.281 | -15.982 | -15.672 | -15.375 | -15.085 | -15.156 | -27 | -83 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 17.486 | 17.308 | 17.015 | 16.703 | 16.379 | 16.069 | 15.763 | 15.836 | 29 | 86 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Adibiocris S.r.l.